vs
Inotiv, Inc.（NOTV）与OneMedNet Corp（ONMD）财务数据对比。点击上方公司名可切换其他公司
Inotiv, Inc.的季度营收约是OneMedNet Corp的135.8倍（$120.9M vs $890.0K）。Inotiv, Inc.净利率更高（-23.5% vs -352.8%，领先329.3%）。OneMedNet Corp同比增速更快（3323.1% vs 0.8%）。OneMedNet Corp自由现金流更多（$-1.7M vs $-10.6M）。过去两年OneMedNet Corp的营收复合增速更高（89.4% vs 0.8%）
Inotiv公司是一家注册于美国印第安纳州的合同研究组织，总部位于该州拉斐特市。公司设有两大核心业务板块：发现与安全评估业务（DSA）以及研究模型与服务业务（RMS），可为小分子候选药物、生物治疗产品及生物医疗设备提供安全评估、分析、代谢研究、CMC及法规咨询等药物开发与环境科学相关服务。
OneMedNet Corp是一家总部位于美国的医疗科技企业，提供面向医学影像与患者健康信息的安全云数据共享及工作流解决方案，服务覆盖医疗机构、支付方及生命科学领域机构，核心运营市场为北美地区。
NOTV vs ONMD — 直观对比
营收规模更大
NOTV
是对方的135.8倍
$890.0K
营收增速更快
ONMD
高出3322.2%
0.8%
净利率更高
NOTV
高出329.3%
-352.8%
自由现金流更多
ONMD
多$8.9M
$-10.6M
两年增速更快
ONMD
近两年复合增速
0.8%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $120.9M | $890.0K |
| 净利润 | $-28.4M | $-3.1M |
| 毛利率 | — | 20.7% |
| 营业利润率 | -13.5% | -353.4% |
| 净利率 | -23.5% | -352.8% |
| 营收同比 | 0.8% | 3323.1% |
| 净利润同比 | -2.7% | -32.3% |
| 每股收益（稀释后） | $-0.83 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NOTVONMD
| Q4 25 | $120.9M | $890.0K | ||
| Q3 25 | $138.1M | $177.0K | ||
| Q2 25 | $130.7M | $155.0K | ||
| Q1 25 | $124.3M | $137.0K | ||
| Q4 24 | $119.9M | $26.0K | ||
| Q3 24 | $130.4M | $142.0K | ||
| Q2 24 | $105.8M | $227.0K | ||
| Q1 24 | $119.0M | $248.0K |
净利润NOTVONMD
| Q4 25 | $-28.4M | $-3.1M | ||
| Q3 25 | $-8.6M | $-741.0K | ||
| Q2 25 | $-17.6M | $3.0M | ||
| Q1 25 | $-14.9M | $-1.9M | ||
| Q4 24 | $-27.6M | $-2.4M | ||
| Q3 24 | $-18.9M | $-2.1M | ||
| Q2 24 | $-26.1M | $-3.6M | ||
| Q1 24 | $-48.1M | $-2.1M |
毛利率NOTVONMD
| Q4 25 | — | 20.7% | ||
| Q3 25 | — | -125.4% | ||
| Q2 25 | — | -155.5% | ||
| Q1 25 | — | -163.5% | ||
| Q4 24 | — | -100.0% | ||
| Q3 24 | — | -59.2% | ||
| Q2 24 | — | -44.9% | ||
| Q1 24 | — | -27.8% |
营业利润率NOTVONMD
| Q4 25 | -13.5% | -353.4% | ||
| Q3 25 | -4.9% | -1262.7% | ||
| Q2 25 | -4.3% | -1331.0% | ||
| Q1 25 | -2.4% | -1623.4% | ||
| Q4 24 | -12.9% | -10438.5% | ||
| Q3 24 | -10.1% | -1645.1% | ||
| Q2 24 | -19.6% | -1081.1% | ||
| Q1 24 | -36.2% | -847.2% |
净利率NOTVONMD
| Q4 25 | -23.5% | -352.8% | ||
| Q3 25 | -6.2% | -418.6% | ||
| Q2 25 | -13.5% | 1923.9% | ||
| Q1 25 | -12.0% | -1388.3% | ||
| Q4 24 | -23.0% | -9126.9% | ||
| Q3 24 | -14.5% | -1449.3% | ||
| Q2 24 | -24.7% | -1581.1% | ||
| Q1 24 | -40.4% | -850.4% |
每股收益（稀释后）NOTVONMD
| Q4 25 | $-0.83 | $-0.06 | ||
| Q3 25 | $-0.14 | $-0.01 | ||
| Q2 25 | $-0.51 | $0.07 | ||
| Q1 25 | $-0.44 | $-0.06 | ||
| Q4 24 | $-1.02 | $-0.07 | ||
| Q3 24 | $-0.73 | $-0.07 | ||
| Q2 24 | $-1.00 | $-0.14 | ||
| Q1 24 | $-1.86 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.7M | $585.0K |
| 总债务越低越好 | $405.8M | $220.0K |
| 股东权益账面价值 | $109.0M | $-3.0M |
| 总资产 | $734.3M | $2.2M |
| 负债/权益比越低杠杆越低 | 3.72× | — |
8季度趋势，按日历期对齐
现金及短期投资NOTVONMD
| Q4 25 | $12.7M | $585.0K | ||
| Q3 25 | $21.7M | $149.0K | ||
| Q2 25 | $6.2M | $122.0K | ||
| Q1 25 | $19.3M | $144.0K | ||
| Q4 24 | $38.0M | $172.0K | ||
| Q3 24 | $21.4M | $1.9M | ||
| Q2 24 | $14.4M | $407.0K | ||
| Q1 24 | $32.7M | $174.0K |
总债务NOTVONMD
| Q4 25 | $405.8M | $220.0K | ||
| Q3 25 | $402.1M | — | ||
| Q2 25 | $396.5M | — | ||
| Q1 25 | $399.5M | $2.3M | ||
| Q4 24 | $396.0M | $2.3M | ||
| Q3 24 | $393.3M | $2.3M | ||
| Q2 24 | $382.4M | $2.4M | ||
| Q1 24 | $380.6M | — |
股东权益NOTVONMD
| Q4 25 | $109.0M | $-3.0M | ||
| Q3 25 | $136.0M | $-3.9M | ||
| Q2 25 | $143.8M | $-3.8M | ||
| Q1 25 | $157.7M | $-16.6M | ||
| Q4 24 | $169.8M | $-15.9M | ||
| Q3 24 | $170.5M | $-14.3M | ||
| Q2 24 | $182.1M | $-19.2M | ||
| Q1 24 | $207.2M | $-15.7M |
总资产NOTVONMD
| Q4 25 | $734.3M | $2.2M | ||
| Q3 25 | $771.1M | $1.5M | ||
| Q2 25 | $759.7M | $2.3M | ||
| Q1 25 | $766.0M | $1.7M | ||
| Q4 24 | $772.9M | $3.7M | ||
| Q3 24 | $781.4M | $4.4M | ||
| Q2 24 | $774.6M | $1.0M | ||
| Q1 24 | $815.4M | $750.0K |
负债/权益比NOTVONMD
| Q4 25 | 3.72× | — | ||
| Q3 25 | 2.96× | — | ||
| Q2 25 | 2.76× | — | ||
| Q1 25 | 2.53× | — | ||
| Q4 24 | 2.33× | — | ||
| Q3 24 | 2.31× | — | ||
| Q2 24 | 2.10× | — | ||
| Q1 24 | 1.84× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.4M | $-1.7M |
| 自由现金流经营现金流 - 资本支出 | $-10.6M | $-1.7M |
| 自由现金流率自由现金流/营收 | -8.8% | -193.0% |
| 资本支出强度资本支出/营收 | 4.3% | 0.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-28.7M | — |
8季度趋势，按日历期对齐
经营现金流NOTVONMD
| Q4 25 | $-5.4M | $-1.7M | ||
| Q3 25 | $14.3M | $-1.6M | ||
| Q2 25 | $-7.4M | $-2.3M | ||
| Q1 25 | $-12.8M | $-1.9M | ||
| Q4 24 | $-4.5M | $-2.0M | ||
| Q3 24 | $-2.4M | $-1.9M | ||
| Q2 24 | $-14.8M | $-1.5M | ||
| Q1 24 | $16.9M | $-1.5M |
自由现金流NOTVONMD
| Q4 25 | $-10.6M | $-1.7M | ||
| Q3 25 | $11.6M | — | ||
| Q2 25 | $-11.5M | $-2.3M | ||
| Q1 25 | $-18.3M | $-2.0M | ||
| Q4 24 | $-9.0M | $-2.0M | ||
| Q3 24 | $-7.7M | $-1.9M | ||
| Q2 24 | $-19.2M | $-1.5M | ||
| Q1 24 | $9.9M | $-1.6M |
自由现金流率NOTVONMD
| Q4 25 | -8.8% | -193.0% | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | -8.8% | -1475.5% | ||
| Q1 25 | -14.7% | -1425.5% | ||
| Q4 24 | -7.5% | -7811.5% | ||
| Q3 24 | -5.9% | -1346.5% | ||
| Q2 24 | -18.2% | -663.9% | ||
| Q1 24 | 8.3% | -626.2% |
资本支出强度NOTVONMD
| Q4 25 | 4.3% | 0.6% | ||
| Q3 25 | 1.9% | 0.0% | ||
| Q2 25 | 3.1% | 1.9% | ||
| Q1 25 | 4.4% | 3.6% | ||
| Q4 24 | 3.7% | 134.6% | ||
| Q3 24 | 4.1% | 6.3% | ||
| Q2 24 | 4.2% | 0.4% | ||
| Q1 24 | 5.9% | 2.4% |
现金转化率NOTVONMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NOTV
| Research Models And Services Segment | $72.9M | 60% |
| Discovery And Safety Assessment Segment | $48.0M | 40% |
ONMD
暂无分部数据
